CompoAtlas

R1 BCAA

Natural health product licensed in Canada

Licence holder
Rule One Proteins
NPN or DIN-HM
80079523
Status
Active licence
Licence date
18 August 2017
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
L-Leucine

Source : L-Leucine

1.25 GrammesNot calculated
L-Isoleucine

Source : L-isoleucine

0.625 GrammesNot calculated
L-valine

Source : L-valine

0.625 GrammesNot calculated

Non-medicinal ingredients

Acide citrique, Acésulfame potassium, Bleu FD&C n° 1, Lécithine, Citrate de potassium, Sucralose

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Portion(s)1 day

Uses authorised in Canada

Workout supplement. Athletic support. Source of (an) essential amino acid(s) for the maintenance of good health. Source of (an) (essential) amino acid(s) involved in muscle protein synthesis. Assists in the building of lean muscle [tissue/mass] when combined with regular [weight/resistance] training and a healthy balanced diet. Source of branched chain amino acids (BCAAs), which are involved in protein synthesis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80079523

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line